Matthias D Hofer

Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays

Wing Hung Wong, Rameen Beroukhim, Levi A Garraway, 2006, PLoS Comput. Biol..

Protein markers of malignant potential in penile and vulvar lichen sclerosus.

Matthias D Hofer, Ximing J. Yang, M. Hofer, 2013, The Journal of urology.

Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.

Stephanie Daignault, Matthias D Hofer, Mark A Rubin, 2006, Cancer research.

Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.

David L Rimm, Arul M Chinnaiyan, Matthias D Hofer, 2004, The American journal of pathology.

Defining aggressive prostate cancer using a 12-gene model.

Alberto Riva, Francesca Demichelis, Arul M Chinnaiyan, 2006, Neoplasia.

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.

Matthias D Hofer, Mark A Rubin, Peter Möller, 2007, Human pathology.

Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.

Matthias D Hofer, Mark A Rubin, Giancarlo Albo, 2006, Neoplasia.

Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.

Ronglai Shen, Arul M Chinnaiyan, Matthias D Hofer, 2004, Neoplasia.